View all trials
Showing 70 results

The table can be sorted by “Study title” or “Protocol ID” sorted alphabetically in either Ascending (default) or Descending (on second click) order.
The default sorting is by “Study title” in alphabetical ascending order.

Study titleProtocol IDDisease type(s)Location(s)Eligibility criteriaStatus
 Page 1 of 7, items 1 to 10 of 70.
A Clinical and Molecular Risk-Directed Therapy For Newly Diagnosed Medulloblastoma SJMB12
Brain and Spinal Tumours
Medulloblastoma/PNET
Children's Hospital at WestmeadSydney
Perth Children's HospitalPerth
Queensland Children's HospitalBrisbane
Royal Children's Hospital Melbourne
Starship Children's HospitalAuckland, NZ
Sydney Children's Hospital
External site Open
A clinical trial of donor-derived WT1 specific T cells for prevention of relapse in combination with multiple pathogen specific T cells for prevention of infection in patients undergoing allogeneic haemopoietic stem cell transplant for acute myeloid leukaemia INTACT-WT1
Leukaemia
AML
Children's Hospital at WestmeadSydney
Open
A multicenter study of apheresis collection of peripheral blood mononuclear cells (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial. CCtl019B2206
Royal Children's Hospital Melbourne
Open
A Phase 1 Study of Intravenous EGFR-ErbituxEDVSMIT (EEDVSMit) in Children with Recurrent / Refractory Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor (EGFR). ECREST
Children's Hospital at WestmeadSydney
Sydney Children's Hospital
Open
A Phase 1/2 Study of the Oral TRK Inhibitor LOXO-101 in Pediatric Patients With Advanced Solid or Primary Central Nervous System Tumors LOXO-TRK-15003
Sydney Children's Hospital
Open
A Phase 1/2 Study of the TRK Inhibitor LOXO-195 in Adult and Pediatric Subjects With Previously Treated NTRK Fusion Cancers LOXO-EXT-17005
Sydney Children's Hospital
Open
A phase 2 study of reduced therapy for newly diagnosed average-risk WNT-driven medulloblastoma patients ACNS1422
Women and Children's HospitalAdelaide
Open
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients ACNS1422
John Hunter Children's HospitalNewcastle
Perth Children's HospitalPerth
Open
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors AGCT1531
Children's Hospital at WestmeadSydney
John Hunter Children's HospitalNewcastle
Perth Children's HospitalPerth
Sydney Children's Hospital
Open
A Phase I Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects with Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma EZH102
Solid tumours
Children's Hospital at WestmeadSydney
Queensland Children's HospitalBrisbane
Royal Children's Hospital Melbourne
Sydney Children's Hospital
Open